Literature DB >> 3106714

Multiple implantation of normal amnion into cattle with generalized glycogenosis type II.

J M Howell, P R Dorling, P N Dimarco, E G Taylor.   

Abstract

One normal and two carrier calves, and two calves affected by generalized glycogenosis type II were given multiple transplants of normal bovine amnion inserted below the external oblique abdominal muscle in the flank. The interval between transplants was approximately 5 months. The amniotic tissue was not acutely rejected but a host versus graft reaction did occur. The level of acid alpha-glucosidase activity in the amniotic tissue fell rapidly but was still present 2 months after transplantation. Enzyme levels in blood or other tissues did not rise. Excess glycogen deposition and muscle damage occurred in the affected calves and appeared to progress at a rate similar to that in untreated affected animals. One of the affected animals died aged 16 months, which was the same age as the longest surviving non-treated animal in our herd. The other treated animal died aged 24 months.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106714     DOI: 10.1007/bf01799481

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  10 in total

1.  A rapid method for the determination of glycogen content and radioactivity in small quantities of tissue or isolated hepatocytes.

Authors:  T M Chan; J H Exton
Journal:  Anal Biochem       Date:  1976-03       Impact factor: 3.365

2.  Generalized glycogenosis in beef shorthorn cattle--heterozygote detection.

Authors:  R D Jolly; N S Van-de-Water; R B Richards; P R Dorling
Journal:  Aust J Exp Biol Med Sci       Date:  1977-04

Review 3.  Advances in the treatment of inherited metabolic diseases.

Authors:  R J Desnick; G A Grabowski
Journal:  Adv Hum Genet       Date:  1981

4.  Expression of HLA antigens, beta 2-microglobulin and enzymes by human amniotic epithelial cells.

Authors:  M Adinolfi; C A Akle; I McColl; A H Fensom; L Tansley; P Connolly; B L Hsi; W P Faulk; P Travers; W F Bodmer
Journal:  Nature       Date:  1982-01-28       Impact factor: 49.962

5.  Exchange of lysosomal enzymes between cells.

Authors:  M F Dean; S Diment
Journal:  Biochem Soc Trans       Date:  1984-06       Impact factor: 5.407

6.  Strategies for the correction of enzymatic deficiencies in patients with mucopoly saccharidoses.

Authors:  M Adinolfi; S Brown
Journal:  Dev Med Child Neurol       Date:  1984-06       Impact factor: 5.449

7.  Bovine generalised glycogenosis type II. Uptake of lysosomal alpha-glucosidase by cultured skeletal muscle and reversal of glycogen accumulation.

Authors:  P N Di Marco; J M Howell; P R Dorling
Journal:  FEBS Lett       Date:  1985-10-14       Impact factor: 4.124

8.  Immunogenicity of human amniotic epithelial cells after transplantation into volunteers.

Authors:  C A Akle; M Adinolfi; K I Welsh; S Leibowitz; I McColl
Journal:  Lancet       Date:  1981-11-07       Impact factor: 79.321

9.  Direct enzyme transfer from lymphocytes corrects a lysosomal storage disease.

Authors:  D Abraham; H Muir; I Olsen; B Winchester
Journal:  Biochem Biophys Res Commun       Date:  1985-06-14       Impact factor: 3.575

10.  The uptake of enzymes into lysosomes: an overview.

Authors:  E F Neufeld
Journal:  Birth Defects Orig Artic Ser       Date:  1980
  10 in total
  3 in total

Review 1.  Enzyme-replacement therapy: problems and prospects.

Authors:  B Rademaker; J Raber
Journal:  Pharm Weekbl Sci       Date:  1989-10-20

2.  Intravenous administration of phosphorylated acid alpha-glucosidase leads to uptake of enzyme in heart and skeletal muscle of mice.

Authors:  A T Van der Ploeg; M A Kroos; R Willemsen; N H Brons; A J Reuser
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

3.  Hypopyon after Primary Cryopreserved Amniotic Membrane Transplantation for Sterile Corneal Ulceration: A Case Report and Review of the Literature.

Authors:  Kostas G Boboridis; Dimitrios G Mikropoulos; Nick S Georgiadis
Journal:  Case Rep Ophthalmol Med       Date:  2021-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.